Pierre Blanchard: Silke Gillessen and Bertrand Tombal, on intermittent ADT/ARPI in metastatic prostrate cancer

Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X:

“Excellent discussion by Silke Gillessen, Bertrand Tombal, on intermittent ADT/ARPI in hormone naïve metastatic prostrate cancer at GETUG research days.

New trials needed, especially for patients with deep PSA response (<0,2 ng/ml) after dual ADT/ARPI.”